UnitedHealth Group reported strong revenue growth and reaffirmed their full-year guidance, highlighting steady performance. Management expressed confidence in accelerated earnings growth for 2016, improvements in Medicare Stars ratings, and better results from the public exchange business. The positive outlook and optimistic tone are likely to have a positive impact on the stock price in the short term.

[1]